THE RED BOOK(더 레드 북) - 우리는 질병의 고통 속에 살 이유가 없다

Darrick Kim(대릭 김)
약력
ㆍUC Irvine 학부 및 대학원 졸업 (PhD, Organic Chemistry)
ㆍUC Irvine, School of Medicine, Department of Neuropathology, Research Associate
ㆍPurdue University, College of Pharmacy (약대) Postdoctoral Stint (Drug Discovery
against Solid Tumor Using Natural Products)
ㆍ일리노이 주립대 약대 교수 역임 (University of Illinois at Chicago, College of
Pharmacy, Department of Medicinal Chemistry and Pharmacognosy, Program for
Collaborative Research in Pharmaceutical Science (PCRPS) and Functional Foods for Health)
ㆍInternational University of the Health and Sciences, School of Medicine
ㆍ세계 최초로 약초성분에서 알츠하이머 예방 치료제 개발 방법 학계 보고
ㆍ알츠하이머 치매 예방 치료제 물질 및 제조공정에 관한 미국 특허 획득 및 출원 (11 건)
ㆍ녹내장 예방 및 황반변성 치료 성분 특허 획득
ㆍ항암제 및 연구에 관한 특허 획득 (13 건)
ㆍ성병 예방 치료제 개발 특허 획득
ㆍ국제 학술지에 40 여편 연구논문 발표
ㆍ투머릭 (강황)에서 뇌신경 세포 활성 및 알츠하이머 치료 물질 Calebin-A 를 세계
최초로 발견 학계보고

현재

ㆍKorea Life Source (주) Founder/CEO
ㆍCore Life Source, Inc., Founder/CEO
ㆍCurXceL Corp., Founder/CEO
ㆍGLLC (Global Life Laboratory Corp., Co-Founder/Director/Board Member
ㆍJoh-Dar Corp. Co-Founder/Chief Science & Technology Officer

Journal Editorial/Reviewer Positions

ㆍJournal of Natural Products
ㆍBioorganic and Medicinal Chemistry
ㆍJournal of Organic Chemistry
ㆍOrganic Letters
ㆍJournal of Agricultural and Food Chemistry
ㆍFood and Chemical Toxicology
ㆍCombinatorial Chemistry & High Throughput Screening

Major Achievements

ㆍDiscovery and development of drug candidates for treatment and prevention of AD
ㆍDiscovery and development of Calebin-A
ㆍDiscovery and development of drug candidates for treatment against solid tumors
ㆍDiscovery and development of drug candidates for treatment against melanoma
ㆍDiscovery and development of drug candidates for treatment against glaucoma and
macular degeneration
ㆍDiscovery and development of drug candidates and formulation for treatment
against chronic inflammatory diseases
ㆍDiscovery and development of methods to treat chronic inflammatory diseases
ㆍDevelopment of Optimum Health Program (OHP) programs to treat non-
communicable inflammatory diseases